102 related articles for article (PubMed ID: 8254388)
1. Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography.
Voipio-Pulkki LM; Nuutila P; Knuuti MJ; Ruotsalainen U; Haaparanta M; Teräs M; Wegelius U; Koivisto VA
J Nucl Med; 1993 Dec; 34(12):2064-7. PubMed ID: 8254388
[TBL] [Abstract][Full Text] [Related]
2. Different alterations in the insulin-stimulated glucose uptake in the athlete's heart and skeletal muscle.
Nuutila P; Knuuti MJ; Heinonen OJ; Ruotsalainen U; Teräs M; Bergman J; Solin O; Yki-Järvinen H; Voipio-Pulkki LM; Wegelius U
J Clin Invest; 1994 May; 93(5):2267-74. PubMed ID: 8182160
[TBL] [Abstract][Full Text] [Related]
3. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography.
Paternostro G; Camici PG; Lammerstma AA; Marinho N; Baliga RR; Kooner JS; Radda GK; Ferrannini E
J Clin Invest; 1996 Nov; 98(9):2094-9. PubMed ID: 8903329
[TBL] [Abstract][Full Text] [Related]
4. Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation.
Tietge UJ; Selberg O; Kreter A; Bahr MJ; Pirlich M; Burchert W; Müller MJ; Manns MP; Böker KH
Liver Transpl; 2004 Aug; 10(8):1030-40. PubMed ID: 15390330
[TBL] [Abstract][Full Text] [Related]
5. Mismatch between insulin-mediated glucose uptake and blood flow in the heart of patients with Type II diabetes.
Iozzo P; Chareonthaitawee P; Rimoldi O; Betteridge DJ; Camici PG; Ferrannini E
Diabetologia; 2002 Oct; 45(10):1404-9. PubMed ID: 12378381
[TBL] [Abstract][Full Text] [Related]
6. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
[TBL] [Abstract][Full Text] [Related]
7. Organ-specific insulin resistance in patients with noninsulin-dependent diabetes mellitus and hypertension.
Yokoyama I; Ohtake T; Momomura S; Yonekura K; Yamada N; Nishikawa J; Sasaki Y; Omata M
J Nucl Med; 1998 May; 39(5):884-9. PubMed ID: 9591594
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative.
Knuuti MJ; Yki-Järvinen H; Voipio-Pulkki LM; Mäki M; Ruotsalainen U; Härkönen R; Teräs M; Haaparanta M; Bergman J; Hartiala J; Wegelius U; Nuutila P
J Nucl Med; 1994 Jun; 35(6):989-98. PubMed ID: 8195886
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes.
Nuutila P; Knuuti J; Ruotsalainen U; Koivisto VA; Eronen E; Teräs M; Bergman J; Haaparanta M; Voipio-Pulkki LM; Viikari J
Am J Physiol; 1993 May; 264(5 Pt 1):E756-62. PubMed ID: 8498497
[TBL] [Abstract][Full Text] [Related]
10. Impact of type 2 diabetes on myocardial insulin sensitivity to glucose uptake and perfusion in patients with coronary artery disease.
Søndergaard HM; Bøttcher M; Marie Madsen M; Schmitz O; Hansen SB; Nielsen TT; Bøtker HE
J Clin Endocrinol Metab; 2006 Dec; 91(12):4854-61. PubMed ID: 16984986
[TBL] [Abstract][Full Text] [Related]
11. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance.
Iozzo P; Chareonthaitawee P; Dutka D; Betteridge DJ; Ferrannini E; Camici PG
Diabetes; 2002 Oct; 51(10):3020-4. PubMed ID: 12351442
[TBL] [Abstract][Full Text] [Related]
12. Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET.
Ohtake T; Yokoyama I; Watanabe T; Momose T; Serezawa T; Nishikawa J; Sasaki Y
J Nucl Med; 1995 Mar; 36(3):456-63. PubMed ID: 7884509
[TBL] [Abstract][Full Text] [Related]
13. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography.
Knuuti MJ; Nuutila P; Ruotsalainen U; Saraste M; Härkönen R; Ahonen A; Teräs M; Haaparanta M; Wegelius U; Haapanen A
J Nucl Med; 1992 Jul; 33(7):1255-62. PubMed ID: 1613561
[TBL] [Abstract][Full Text] [Related]
14. [Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading].
Brink I; Nitzsche EU; Mix M; Schindler T; Hentschel M; Högerle S; Moser E
Nuklearmedizin; 2003 Feb; 42(1):39-44. PubMed ID: 12601453
[TBL] [Abstract][Full Text] [Related]
15. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography.
Schelbert HR
J Nucl Med; 1992 Jul; 33(7):1263-6. PubMed ID: 1613562
[No Abstract] [Full Text] [Related]
16. Myocardial glucose uptake in patients with NIDDM and stable coronary artery disease.
Mäki M; Nuutila P; Laine H; Voipio-Pulkki LM; Haaparanta M; Solin O; Knuuti JM
Diabetes; 1997 Sep; 46(9):1491-6. PubMed ID: 9287051
[TBL] [Abstract][Full Text] [Related]
17. [Metabolism of the ischemic myocardium in non-insulin-dependent diabetes].
Uccella R
Minerva Med; 1989 Sep; 80(9):965-8. PubMed ID: 2812481
[TBL] [Abstract][Full Text] [Related]
18. In vivo effects of insulin on tumor and skeletal muscle glucose metabolism in patients with lymphoma.
Minn H; Nuutila P; Lindholm P; Ruotsalainen U; Bergman J; Teräs M; Knuuti MJ
Cancer; 1994 Mar; 73(5):1490-8. PubMed ID: 8111717
[TBL] [Abstract][Full Text] [Related]
19. Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed quantitatively by dynamic positron emission tomography.
vom Dahl J; Herman WH; Hicks RJ; Ortiz-Alonso FJ; Lee KS; Allman KC; Wolfe ER; Kalff V; Schwaiger M
Circulation; 1993 Aug; 88(2):395-404. PubMed ID: 8339403
[TBL] [Abstract][Full Text] [Related]
20. Myocardial glucose uptake evaluated by positron emission tomography and fluorodeoxyglucose during hyperglycemic clamp in IDDM patients. Role of free fatty acid and insulin levels.
Monti LD; Lucignani G; Landoni C; Moresco RM; Piatti P; Stefani I; Pozza G; Fazio F
Diabetes; 1995 May; 44(5):537-42. PubMed ID: 7729612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
